Stockscreener 앱 받기
0.77
2.80%
0.021
전일 마감가:
$0.749
열려 있는:
$0.73
하루 거래량:
77,881
Relative Volume:
0.70
시가총액:
$14.29M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-2.8519
EPS:
-0.27
순현금흐름:
$-13.77M
1주 성능:
+0.65%
1개월 성능:
-67.78%
6개월 성능:
-84.75%
1년 성능:
-83.19%
1일 변동 폭
$0.7201
$0.779
1주일 범위
$0.7145
$0.80
52주 변동 폭
$0.6601
$7.48
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.77 | 14.29M | 62.71M | -10.48M | -13.77M | -0.27 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
PRPH (ProPhase Labs) Growth Rank : 9 (As of Nov. 26, 2024) - GuruFocus.com
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript - MSN
ProPhase Labs plummets 21%, prices $3M equity offering - MSN
ProPhase Labs 4.17M share Spot Secondary priced at $.72 - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strat - GuruFocus.com
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... - Yahoo Finance
ProPhase Labs Inc (PRPH) Q3 2024 Earnings Call Highlights: Strategic Launches and Financial ... By GuruFocus - Investing.com Canada
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - EIN News
Earnings call: Prophase Labs' Q3 2024 reveals strategic growth initiatives By Investing.com - Investing.com Australia
ProPhase Labs: Strategic Moves for Future Growth - TipRanks
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2024 - The Manila Times
ProPhase Labs Announces Closing of Public Offering of Common Stock - GlobeNewswire
Wendys Company (WEN-Q) QuotePress Release - The Globe and Mail
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024 - GlobeNewswire
ProPhase Labs to Host Q3 2024 Earnings Call on November 13 | PRPH Stock | PRPH Stock News - StockTitan
ProPhase Labs announces proposed public offering of common stock - MSN
Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding - Simply Wall St
It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks - Simply Wall St
S&P 500 Tops 6,000; Sezzle Shares Spike Higher - Benzinga
Dow Tops 44,000; US Consumer Sentiment Increases In NovemberNature's Miracle Holding (NASDAQ:NMHI) - Benzinga
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
PRPHProPhase Labs, Inc. Latest Stock News & Market Updates - StockTitan
ProPhase Labs Prices of Public Offering of Common Stock - citybiz
ProPhase Labs Raises $3M in Public Offering at $0.72 Per Share, Stock Dilution Ahead | PRPH Stock News - StockTitan
ProPhase Labs Announces Pricing of Public Offering of Common Stock - GlobeNewswire
ProPhase Labs plans public stock offering - Investing.com India
Form FWP ProPhase Labs, Inc. Filed by: ProPhase Labs, Inc. - StreetInsider.com
ProPhase Labs Announces Proposed Public Offering of Common Stock - GlobeNewswire
ProPhase Labs stock hits 52-week low at $1.99 amid market challenges - Investing.com
ProPhase Labs Launches DNA Complete®: Transforming - GlobeNewswire
ProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced Ancestry - StockTitan
ProPhase Labs to Present at the 2024 ThinkEquity Conference - GlobeNewswire
Enphase Energy Inc (ENPH-Q) QuotePress Release - The Globe and Mail
ProPhase Labs projects significant 2025 earnings - Investing.com
ProPhase Labs Announces Positive Updates on Strategic - GlobeNewswire
ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 - StockTitan
Down 34% and 57%, Wall Street Says These 2 Stocks Will Gain 230% - MSN
ProPhase Labs announces change in accounting firm - Investing.com India
ProPhase Labs announces change in accounting firm By Investing.com - Investing.com South Africa
* ProPhase Labs, Inc. Announces final results of its tender offer - Reuters
ProPhase Labs stock hits 52-week low at $2.02 By Investing.com - Investing.com Australia
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
0.41%
자본화:
|
볼륨(24시간):